martes, 6 de agosto de 2024

More Immunotherapy Options Approved for Treating Endometrial Cancer

https://www.cancer.gov/news-events/cancer-currents-blog/2024/endometrial-cancer-durvalumab-pembrolizumab-chemotherapy?cid=eb_govdel

No hay comentarios:

Publicar un comentario